Ripe for exploration: the mouse with human antibodies
By Sharon Kingman
Monday, March 17, 2014
LONDON – The advent of mice that produce the full range of human antibodies is set to trigger an explosion in new therapies for human diseases and to revolutionize vaccine research. Derived from embryonic stem cells into which all the genes encoding the entire human antibody repertoire have been inserted, the mice are fertile and apparently normal in every other way. The antibodies the animals produce have all the properties desired for therapeutic antibodies, studies suggest. The breakthrough ends years, if not decades, of attempts aimed at finding a way to produce fully humanized antibodies for therapeutic use.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.